A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD

Clinical trial NCT04320342 · COMPLETED

Trial details

NCT number: NCT04320342
Sponsor: Chiesi Farmaceutici S.p.A.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

COPD COPD Exacerbation

Start date: 2022-04-28
Primary completion: 2026-01-12
Enrollment: 3433

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.